Bayer | BAYN - Beneficio Bruto En Ventas

Precio De Mercado
38.05
Cambio Diario
1.60 4.39%
Mensual
-3.39%
Anual
59.34%
Q2 Expectativa
37.49




Beneficio Bruto En Ventas Cambio Fecha
Air Liquide EUR 8.65B 4.44B 2024-12
Akzo Nobel EUR 936M 102M 2025-12
Alcon AG USD 1.52B 58M 2025-12
Amarin USD 23.17M 961K 2025-12
Arkema EUR 455M 14M 2025-06
AstraZeneca USD 12.61B 225M 2026-03
BASF EUR 3.11B 55M 2025-12
Bayer EUR 5.35B 1.02B 2025-09
Beiersdorf EUR 1.54B 1.16B 2025-06
Corteva USD 1.5B 685M 2025-12
Covestro EUR 488M 64M 2025-09
Essilor EUR 8.3B 547M 2025-12
Fresenius EUR 1.51B 214M 2025-12
Fresenius Medical Care EUR 1.39B 147M 2025-12
Genmab DKK 977M 13M 2025-12
Givaudan CHF 1.55B 140M 2025-12
GlaxoSmithKline GBP 5.75B 429M 2026-03
GRIFOLS EUR 686.84M 56.95M 2025-12
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Johnson Matthey GBP 480M 33M 2024-06
Linde USD 3.27B 969M 2025-12
Lonza CHF 1.29B 248M 2025-06
Merck EUR 2.96B 252M 2025-12
Novartis USD 10.25B 570M 2025-12
Nutrien USD 1.89B 76M 2025-12
Philips EUR 2.29B 377M 2025-12
PPG Industries USD 1.46B 54M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
SAP EUR 6.97B 149M 2026-03
Solvay EUR 265M 13M 2025-09
UCB EUR 3.19B 621M 2025-12
Umicore EUR 308.6M 10.45M 2024-12
Vinci EUR 2.44B 27.34B 2025-06